Obesity Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Obesity stocks.

Obesity Stocks Recent News

Date Stock Title
Nov 21 ESPR Esperion to Participate in Upcoming Piper Sandler 36th Annual Healthcare Conference
Nov 20 AMGN AMGEN ANNOUNCES SENIOR EXECUTIVE RESEARCH APPOINTMENT
Nov 20 NVO More companies covering weight loss drugs for their employees
Nov 20 NVO Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Nov 20 AMGN SLN Stock Down Despite Cholesterol Drug Lowering Lipoprotein Levels
Nov 20 NVO Is Novo Nordisk Stock a Buy Right Now?
Nov 20 NVO RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
Nov 19 NVO Novo Nordisk semaglutide phase 3 trial for MASH meets primary endpoints
Nov 19 NVO Sector Update: Health Care Stocks Decline
Nov 19 AMGN Amgen Stock Has High Implied Volatility. An Iron Condor Takes Advantage.
Nov 19 NVO Novo Nordisk Unusual Options Activity For November 19
Nov 19 AMGN Silence Therapeutics' Zerlasiran Has Competitive Concerns: Analyst
Nov 19 NVO Sector Update: Health Care Stocks Mixed Tuesday Afternoon
Nov 19 MED How Should You Play Medifast Stock at a P/E Multiple of 17.6X?
Nov 19 NVO Novo Erases 2024 Gain, Wiping Out $210 Billion in Value
Nov 19 NVO Market Chatter: Eli Lilly, Novo Nordisk Press Employers to Cover the Cost of Weight-Loss Drugs
Nov 19 NVO Employers Get Pressure to Pay for Drugs Like Wegovy
Nov 18 NVO RFK Jr.'s HHS nomination sparks concern over pharma stocks
Nov 18 AMGN Amgen Sells Off: Keep Calm And Buy The Dip
Nov 18 NVO Novo Nordisk reportedly launches Wegovy in China
Obesity

Obesity is a medical condition in which excess body fat has accumulated to an extent that it may have a negative effect on health. People are generally considered obese when their body mass index (BMI), a measurement obtained by dividing a person's weight by the square of the person's height, is over 30 kg/m2; the range 25–30 kg/m2 is defined as overweight. Some East Asian countries use lower values. Obesity increases the likelihood of various diseases and conditions, particularly cardiovascular diseases, type 2 diabetes, obstructive sleep apnea, certain types of cancer, osteoarthritis, and depression.Obesity is most commonly caused by a combination of excessive food intake, lack of physical activity, and genetic susceptibility. A few cases are caused primarily by genes, endocrine disorders, medications, or mental disorder. The view that obese people eat little yet gain weight due to a slow metabolism is not medically supported. On average, obese people have a greater energy expenditure than their normal counterparts due to the energy required to maintain an increased body mass.Obesity is mostly preventable through a combination of social changes and personal choices. Changes to diet and exercising are the main treatments. Diet quality can be improved by reducing the consumption of energy-dense foods, such as those high in fat or sugars, and by increasing the intake of dietary fiber. Medications can be used, along with a suitable diet, to reduce appetite or decrease fat absorption. If diet, exercise, and medication are not effective, a gastric balloon or surgery may be performed to reduce stomach volume or length of the intestines, leading to feeling full earlier or a reduced ability to absorb nutrients from food.Obesity is a leading preventable cause of death worldwide, with increasing rates in adults and children. In 2015, 600 million adults (12%) and 100 million children were obese in 195 countries. Obesity is more common in women than men. Authorities view it as one of the most serious public health problems of the 21st century. Obesity is stigmatized in much of the modern world (particularly in the Western world), though it was seen as a symbol of wealth and fertility at other times in history and still is in some parts of the world. In 2013, the American Medical Association classified obesity as a disease.

Browse All Tags